We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME (CME) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
For the quarter ended June 2023, CME Group (CME - Free Report) reported revenue of $1.36 billion, up 9.9% over the same period last year. EPS came in at $2.30, compared to $1.97 in the year-ago quarter.
The reported revenue represents a surprise of +1.25% over the Zacks Consensus Estimate of $1.34 billion. With the consensus EPS estimate being $2.18, the EPS surprise was +5.50%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Average daily volume (including NYMEX and COMEX): 22855 thousand versus the five-analyst average estimate of 23070.4 thousand.
Average daily volume - Interest rates (including NYMEX and COMEX): 11273 thousand versus 11295.6 thousand estimated by five analysts on average.
Average daily volume - Equity indexes (including NYMEX and COMEX): 6216 thousand versus the five-analyst average estimate of 6756.51 thousand.
Average daily volume - Foreign exchange (including NYMEX and COMEX): 898 thousand versus the five-analyst average estimate of 911.53 thousand.
Average daily volume - Energy (including NYMEX and COMEX): 2104 thousand compared to the 1989.53 thousand average estimate based on five analysts.
Average daily volume - Agricultural commodities (including NYMEX and COMEX): 1752 thousand versus the five-analyst average estimate of 1538.68 thousand.
Average rate per contract - Metals (including NYMEX and COMEX): $1.49 versus $1.52 estimated by five analysts on average.
Average rate per contract (including NYMEX and COMEX): $0.72 versus the five-analyst average estimate of $0.69.
Average rate per contract - Interest rates (including NYMEX and COMEX): $0.51 versus $0.50 estimated by five analysts on average.
Revenues- Clearing and transaction fees: $1.12 billion versus the seven-analyst average estimate of $1.08 billion. The reported number represents a year-over-year change of +9.2%.
Revenues- Other: $78.80 million versus the seven-analyst average estimate of $74.56 million. The reported number represents a year-over-year change of +29.4%.
Revenues- Market data and information services: $163.10 million versus $162.66 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +7.5% change.
Shares of CME have returned +6.9% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CME (CME) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2023, CME Group (CME - Free Report) reported revenue of $1.36 billion, up 9.9% over the same period last year. EPS came in at $2.30, compared to $1.97 in the year-ago quarter.
The reported revenue represents a surprise of +1.25% over the Zacks Consensus Estimate of $1.34 billion. With the consensus EPS estimate being $2.18, the EPS surprise was +5.50%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average daily volume (including NYMEX and COMEX): 22855 thousand versus the five-analyst average estimate of 23070.4 thousand.
- Average daily volume - Interest rates (including NYMEX and COMEX): 11273 thousand versus 11295.6 thousand estimated by five analysts on average.
- Average daily volume - Equity indexes (including NYMEX and COMEX): 6216 thousand versus the five-analyst average estimate of 6756.51 thousand.
- Average daily volume - Foreign exchange (including NYMEX and COMEX): 898 thousand versus the five-analyst average estimate of 911.53 thousand.
- Average daily volume - Energy (including NYMEX and COMEX): 2104 thousand compared to the 1989.53 thousand average estimate based on five analysts.
- Average daily volume - Agricultural commodities (including NYMEX and COMEX): 1752 thousand versus the five-analyst average estimate of 1538.68 thousand.
- Average rate per contract - Metals (including NYMEX and COMEX): $1.49 versus $1.52 estimated by five analysts on average.
- Average rate per contract (including NYMEX and COMEX): $0.72 versus the five-analyst average estimate of $0.69.
- Average rate per contract - Interest rates (including NYMEX and COMEX): $0.51 versus $0.50 estimated by five analysts on average.
- Revenues- Clearing and transaction fees: $1.12 billion versus the seven-analyst average estimate of $1.08 billion. The reported number represents a year-over-year change of +9.2%.
- Revenues- Other: $78.80 million versus the seven-analyst average estimate of $74.56 million. The reported number represents a year-over-year change of +29.4%.
- Revenues- Market data and information services: $163.10 million versus $162.66 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +7.5% change.
View all Key Company Metrics for CME here>>>Shares of CME have returned +6.9% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.